TAKROZEM 0.1 %, ointment tube, 30 g
Active ingredients: Tacrolimus, Tacrolimus hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Ointmenttube, 30 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TAKROZEM 0,1 %, pommade
- Pharmaceutical form
- pommade
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) polyéthylène basse densité (PEBD) de 30 g
- Marketing authorisation holder
- PIERRE FABRE MEDICAMENT
- Reimbursement according to BDPM
- 15%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Poussées de la dermatite atopique sévère (qui est une maladie chronique inflammatoire de la peau)chez les personnes de plus de 16 ans ; JOURNAL OFFICIEL ; 20/11/18
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Dec 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66080171CIP73014381CIP133400930143810Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TACROLIMUSpommade | 1 mg · 1 g de pommade | FT |
| TACROLIMUS MONOHYDRATÉpommade | 1,022 mg · 1 g de pommade | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.